FRI0064 Right ventricle diastolic dysfunction in early rheumatoid arthritis patients: risk factors and the effect of antirheumatic therapy. (12th June 2018)

• Record Type: Journal Article
• Authors: Kirillova, I.G.; Novikova, D.; Popkova, T.; Udachkina, H.; Markelova, E.; Volkov, A.; Gorbunova, Y.
• Is Part Of: Annals of the rheumatic diseases. Volume 77(2018)Supplement 2
• Page Start: 578
• Page End: 578
• Publication Date: 2018-06-12
• Subjects: Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2018-eular.5586
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Objectives: To determine the frequency of diastolic dysfunction of the right ventricle (RVDD) in patients (pts) with early rheumatoid arthritis (RA) prior to therapy with basic anti-inflammatory drugs (DMARDs), examine its relationship with traditional risk factors of cardiovascular disease and markers of inflammation, to study the effect of antirheumatic therapy administered in accordance with "treat to target" (T2T) principles on RVDD in early RA pts during 18 month follow-up. Methods: A total of 66 pts with early RA (ACR/EULAR criteria, 2010 were included: 71% of women, age 56 46;61 years, disease duration 6 4;8 months; DAS28 5.3 [5.0;6.2], positive for ACCP (100%)/RF (87%), without prior administration of DMARDs and glucocorticoides. All pts underwent blood pressure monitoring (BP), echocardiography, tissue Doppler imaging. Methotrexate (MT) therapy was started in all pts with an escalation of the dose up to 30 mg/week subcutaneously. In case of no remission 3 months later, MT was added with biologic therapy (BT): Adalimumab, Certolizumab pegol, Abatacept, Rituximab. After 18 months 29 (44%) pts achieved remission. Antihypertensive therapy was administered in 51 (77%) pts: ACE inhibitors, ARBs, beta-blockers, calcium antagonists, diuretics. Results: At baseline RVDD was detected in 16 (24%) pts. RVDD related factors that remained associated on a multivariable forward stepwise linear regression analysis were body mass index (BMI) (β-coefficient (95% CI) 0, 3 (-0, 003;−0, 008), SDAI 0, 2 (-0, 009;−0, 001), carotid atherosclerosis (CA) 0, 2 (-0, 3;0, 01), disease duration 0, 2 (-0, 02;0, 001). Multiple coefficient of determination (R2) was 38% (p=0, 03). After 18 months the incidence rate of RVDD decreased from 24% to 18%, p>0.05. The dynamics of diastolic function was multidirectional. RVDD was normalised in 10 (63%) of 16 RA pts with RVDD (p=0.02). All of them had effective control of BP and achieved remission. 67% of pts with normalised RVDD received MT+BT. 5 (31%) pts with new cases of RVDD and 6 pts with preserved RVDD did not reach the target values of BP and RA remission. Conclusions: Presens of CA, higher BMI, SDAI and disease duration strongly associated with the incidence rate of RVDD. A significant decrease of RVDD in case of achieved targeted BP values and RA remission was observed during 18 month therapy of early RA pts in accordance with "T2T" principles Disclosure of Interest: None declared